KCTBASE

Factors predicting radiation pneumonitis in locally advanced non-small cell lung cancer

Radiation Oncology Journal 2011년 29권 3호 p.181 ~ p.190

김명수(Kim Myung-Soo) - Ewha Womans University School of Medicine Department of Radiation Oncology
이지혜(Lee Ji-Hae) - Ewha Womans University School of Medicine Department of Radiation Oncology
하보람(Ha Bo-Ram) - Ewha Womans University School of Medicine Department of Radiation Oncology
이래나(Lee Re-Na) - Ewha Womans University School of Medicine Department of Radiation Oncology

Abstract

Purpose: Thoracic radiotherapy is a major treatment modality of stage III non-small cell lung cancer. The normal lung tissue is sensitive to radiation and radiation pneumonitis is the most important dose-limiting complication of thoracic radiation therapy. This study was performed to identify the clinical and dosimetric parameters related to the risk of radiation pneumonitis after defi nitive radiotherapy in stage III non-small cell cancer patients.

Materials and Methods : The medical records were reviewed for 49 patients who completed defi nitive radiation therapy for locally advanced non-small cell lung cancer from August 2000 to February 2010. Radiation therapy was delivered with the daily dose of 1.8 Gy to 2.0 Gy and the total radiation dose ranged from 50.0 Gy to 70.2 Gy (median, 61.2 Gy). Elective nodal irradiation was delivered at a dose of 45.0 Gy to 50.0 Gy. Seven patients (14.3%) were treated with radiation therapy alone and forty two patients (85.7%) were treated with chemotherapy either sequentially or concurrently.

Results: Twenty-fi ve cases (51.0%) out of 49 cases experienced radiation pneumonitis. According to the radiation pneumonitis grade, 10 (20.4%) were grade 1, 9 (18.4%) were grade 2, 4 (8.2%) were grade 3, and 2 (4.1%) were grade 4. In the univariate analyses, no clinical factors including age, sex, performance status, smoking history, underlying lung disease, tumor location, total radiation dose and chemotherapy were associated with grade ≥2 radiation pneumonitis. In the subgroup analysis of the chemotherapy group, concurrent rather than sequential chemotherapy was signifi cantly related to grade ≥2 radiation pneumonitis comparing sequential chemotherapy. In the univariate analysis with dosimetric factors, mean lung dose (MLD), V20, V30, V40, MLDipsi, V20ipsi, V30ipsi, and V40ipsi were associated with grade ≥2 radiation pneumonitis. In addition, multivariate analysis showed that MLD and V30 were independent predicting factors for grade ≥2 radiation pneumonitis.

Conclusion: Concurrent chemotherapy, MLD and V30 were statistically signifi cant predictors of grade ≥2 radiation pneumonitis in patients with stage III non-small cell lung cancer undergoing defi nitive radiotherapy. The cutoff values for MLD and V30 were 16 Gy and 18%, respectively.

키워드

Non-small cell lung cancer, Radiation therapy, Radiation pneumonitis, Dosimetric factor

KMID : 1038620110290030181

원문 및 링크아웃 정보

등재저널 정보

주제코드

주제명(Target field)

연구대상(Population)

연구참여(Sample size)

대상성별(Gender)

질병특성(Condition Category)

연구환경(Setting)

연구설계(Study Design)

연구기간(Period)

중재방법(Intervention Type)

중재명칭(Intervention Name)

키워드(Keyword)

유효성결과(Recomendation)

Concurrent chemotherapy, MLD and V30 were statistically significant predictors of grade ≥2 radiation pneumonitis in patients with stage III non-small cell lung cancer undergoing definitive radiotherapy

연구비지원(Fund Source)

근거수준평가(Evidence Hierarchy)

출판년도(Year)

참여저자수(Authors)

대표저자

DOI

KCD코드

ICD 03

건강보험코드